• Product NameResiquimod
• Brief DescriptionInhibitors
• Purification99.95%
• Biological ActivityResiquimod is an immune response modifier that acts as a potent TLR 7/8 agonist. Phase 2.
• Target NameTLR agonist
• CAS No. 144875-48-9
• Calculated MW 314.38
• Formulation C17H22N4O2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Others
  SMILES:CCOCC1=NC2=C(N1CC(C)(C)O)C1=C(C=CC=C1)N=C2N |c:6,17,19,22,t:4,15|
  Pathways:Immunology/Inflammation
  Receptor:TLR7; TLR8
  Boling pt:
  Melting pt:
  Solubility:Ethanol: 21 mg/mL warmed (66.79 mM) DMSO: 63 mg/mL (200.39 mM) Water: <1 mg/mL
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Hemmi H, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway..Nat Immunol. 2002, 3(2), 196-200.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting